ABSI
Price
$4.96
Change
-$0.23 (-4.43%)
Updated
Feb 21 closing price
Capitalization
569.68M
24 days until earnings call
BEAM
Price
$30.43
Change
-$2.71 (-8.18%)
Updated
Feb 21 closing price
Capitalization
2.52B
9 days until earnings call
Ad is loading...

ABSI vs BEAM

Header iconABSI vs BEAM Comparison
Open Charts ABSI vs BEAMBanner chart's image
Absci
Price$4.96
Change-$0.23 (-4.43%)
Volume$4.97M
Capitalization569.68M
Beam Therapeutics
Price$30.43
Change-$2.71 (-8.18%)
Volume$1.88M
Capitalization2.52B
ABSI vs BEAM Comparison Chart
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. BEAM commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and BEAM is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ABSI: $5.79 vs. BEAM: $33.49)
Brand notoriety: ABSI and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 162% vs. BEAM: 168%
Market capitalization -- ABSI: $569.68M vs. BEAM: $2.52B
ABSI [@Biotechnology] is valued at $569.68M. BEAM’s [@Biotechnology] market capitalization is $2.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than ABSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 6 TA indicator(s) are bullish while BEAM’s TA Score has 6 bullish TA indicator(s).

  • ABSI’s TA Score: 6 bullish, 4 bearish.
  • BEAM’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ABSI and BEAM are a good buy in the short-term.

Price Growth

ABSI (@Biotechnology) experienced а +17.92% price change this week, while BEAM (@Biotechnology) price change was +24.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.27%. For the same industry, the average monthly price growth was +3.99%, and the average quarterly price growth was +2.35%.

Reported Earning Dates

ABSI is expected to report earnings on May 20, 2025.

BEAM is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.52B) has a higher market cap than ABSI($570M). ABSI YTD gains are higher at: 120.992 vs. BEAM (35.040). ABSI has higher annual earnings (EBITDA): -83.27M vs. BEAM (-160.83M). BEAM has more cash in the bank: 926M vs. ABSI (127M). ABSI has less debt than BEAM: ABSI (12M) vs BEAM (162M). BEAM has higher revenues than ABSI: BEAM (350M) vs ABSI (4.21M).
ABSIBEAMABSI / BEAM
Capitalization570M2.52B23%
EBITDA-83.27M-160.83M52%
Gain YTD120.99235.040345%
P/E RatioN/AN/A-
Revenue4.21M350M1%
Total Cash127M926M14%
Total Debt12M162M7%
TECHNICAL ANALYSIS
Technical Analysis
ABSIBEAM
RSI
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 6 days ago
90%
Momentum
ODDS (%)
Bullish Trend 6 days ago
86%
Bullish Trend 6 days ago
84%
MACD
ODDS (%)
Bullish Trend 6 days ago
90%
Bullish Trend 6 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
88%
Bullish Trend 6 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 6 days ago
82%
Advances
ODDS (%)
Bullish Trend 10 days ago
89%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 17 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
Bullish Trend 6 days ago
88%
Bullish Trend 6 days ago
80%
View a ticker or compare two or three
Ad is loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with CRSP. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
-0.52%
CRSP - ABSI
51%
Loosely correlated
+5.03%
BEAM - ABSI
50%
Loosely correlated
+3.36%
ABCL - ABSI
50%
Loosely correlated
+4.89%
RXRX - ABSI
49%
Loosely correlated
+1.04%
PRME - ABSI
48%
Loosely correlated
+5.28%
More